Impact of preexisting hepatitis C virus genotype 6 NS3, NS5A, and NS5B polymorphisms on the in vitro potency of direct-acting antiviral agents
Author(s):
Fiona McPhee, Joseph Ueland, Vincent Vellucci, Scott Bowden, William Sievert, Nannan Zhou
Details:
Antimicrobial Agents and Chemotherapy, Volume 63, Issue 4, 2019-04-01, Article number e02205-18
Article Link: Click here
Affiliations:
- Monash University
- Bristol Myers Squibb
- The Peter Doherty Institute for Infection and Immunity
- Bristol-Myers Squibb

